CN Stock MarketDetailed Quotes

600211 Tibet Rhodiola Pharmaceutical Holding

Watchlist

38.31
-0.63-1.62%

Market Closed Nov 15 15:00 CST

12.35BMarket Cap16.74P/E (TTM)

Tibet Rhodiola Pharmaceutical Holding Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-3.96%1.62B

35.22%1.91B

47.96%2.17B

63.16%1.86B

29.07%1.69B

53.10%1.41B

56.92%1.47B

49.11%1.14B

79.83%1.31B

20.31%922.9M

Transactional financial assets

17.02%971.12M

4.81%1.11B

-4.96%903.25M

-34.97%515.34M

36.07%829.85M

44.97%1.06B

65.54%950.39M

47.34%792.49M

180.08%609.87M

3,654.81%731.22M

Notes receivable and accounts receivable

23.97%493.47M

5.35%677.15M

18.18%518.88M

48.81%666.56M

-21.91%398.05M

10.55%642.76M

-15.46%439.06M

-16.56%447.91M

9.62%509.71M

21.93%581.43M

-Notes receivable

2,004.02%23.78M

1,087.28%29.37M

3,294.44%78.4M

1,238.72%15.63M

-96.90%1.13M

-96.22%2.47M

-96.11%2.31M

-98.22%1.17M

-2.24%36.52M

133.24%65.46M

-Accounts receivable

18.33%469.69M

1.17%647.78M

0.85%440.48M

45.71%650.93M

-16.12%396.92M

24.09%640.29M

-5.04%436.75M

-5.23%446.74M

10.65%473.19M

14.97%515.97M

Other receivables (including interest and dividends)

70.96%12.33M

-10.04%12.41M

-78.57%12.87M

-6.48%11.82M

-54.38%7.21M

-17.29%13.8M

293.83%60.05M

-1.56%12.63M

-1.68%15.81M

6.10%16.68M

-Other receivable

----

-10.04%12.41M

----

-17.29%13.8M

----

-1.56%12.63M

----

6.10%16.68M

Advance payment

112.92%30.84M

179.91%26.21M

22.70%15.36M

40.24%13.52M

-11.48%14.49M

-25.93%9.36M

17.68%12.52M

-25.14%9.64M

-59.56%16.37M

-59.95%12.64M

Inventories

19.01%137.48M

28.17%128.7M

15.36%109.37M

11.49%111.43M

14.60%115.52M

-1.82%100.41M

-22.22%94.81M

-27.21%99.95M

-15.31%100.8M

27.04%102.28M

Receivable financing

-33.72%166.12M

-4.79%205.38M

-39.17%145.39M

6.96%190.15M

94.40%250.64M

205.41%215.72M

93.96%239.03M

86.06%177.77M

78.08%128.93M

4.44%70.63M

Other current assets

46.62%62.25M

172.61%63.5M

26.62%37.13M

7.42%34.26M

85.59%42.46M

44.06%23.29M

-64.48%29.32M

-62.16%31.89M

-42.71%22.88M

-17.00%16.17M

Total current assets

4.44%3.49B

18.88%4.14B

18.88%3.92B

25.47%3.4B

23.38%3.34B

41.75%3.48B

38.23%3.29B

24.30%2.71B

59.73%2.71B

65.99%2.45B

Non Current assets

Other equity investment

238.25%33.83M

--33.83M

--13.83M

--11M

--10M

----

Other non-current financial assets

-35.60%12.78M

0.00%19.84M

Investment real estate

-5.16%128.55M

-4.99%130.39M

-4.94%132.2M

-4.84%134.07M

-5.02%135.55M

-5.05%137.24M

-4.98%139.07M

-4.92%140.89M

354.23%142.71M

354.19%144.54M

Long-term equity investment

-13.24%89.76M

-12.87%90.47M

-12.00%91.29M

-15.53%92.85M

-3.87%103.47M

-3.81%103.84M

-4.23%103.74M

-0.44%109.91M

-5.68%107.63M

-8.62%107.96M

Fixed assets

----

35.28%521.29M

----

-20.25%385.33M

----

-18.91%395.87M

----

188.17%483.16M

Constru in process

----

-70.61%63.71M

----

-23.85%216.81M

----

-43.56%153.6M

----

-35.71%284.7M

Intangible assets

-55.18%181.73M

-54.13%190.55M

-51.45%196.24M

-51.39%202.46M

-5.98%405.44M

-0.38%415.38M

0.22%404.23M

1.17%416.48M

-51.73%431.24M

-53.92%416.97M

Development expenditure

2.85%1.33M

4.05%1.34M

3.23%1.32M

3.07%1.31M

3.10%1.29M

2.91%1.28M

-97.34%1.28M

-97.17%1.27M

-97.30%1.26M

-96.33%1.25M

Goodwill

0.00%8.88M

Long deferred expense

-48.18%456.41K

-44.09%605.33K

-64.07%451.87K

-58.91%625.14K

-58.03%880.75K

-55.40%1.08M

-54.37%1.26M

-47.02%1.52M

36.94%2.1M

218.70%2.43M

Deferred tax assets

59.17%135.67M

89.95%134.97M

65.69%116.47M

61.87%115.48M

25.76%85.24M

14.04%71.06M

2.85%70.3M

6.22%71.34M

144.79%67.78M

192.09%62.31M

Usufruct assets

-15.53%1.89M

47.75%2.18M

117.60%3.19M

8.44%2.07M

-17.43%2.23M

-52.52%1.47M

-59.98%1.46M

-54.95%1.91M

-59.48%2.71M

-57.54%3.1M

Other non current assets

32.12%10.7M

8.97%9.74M

-30.60%6.9M

-92.86%4.72M

-87.03%8.1M

-84.53%8.94M

-85.91%9.94M

55.87%66.07M

-38.46%62.42M

-73.73%57.81M

Total non current assets

-14.44%1.18B

-12.43%1.2B

-13.93%1.17B

-14.64%1.18B

-14.85%1.38B

-13.92%1.37B

-17.56%1.36B

-14.39%1.39B

-21.34%1.62B

-19.45%1.59B

Total assets

-1.07%4.67B

10.03%5.34B

9.28%5.09B

11.90%4.59B

9.09%4.72B

19.83%4.85B

15.39%4.66B

7.81%4.1B

15.30%4.33B

17.10%4.05B

Liabilities

Current liabilities

Short term loan

-30.07%528.32M

18.64%746.4M

40.93%761.55M

2.86%499.99M

16.17%755.52M

14.30%629.14M

-5.20%540.37M

-9.08%486.1M

58.63%650.38M

117.53%550.41M

Notes payable and accounts payable

21.56%54.07M

54.13%66.59M

-12.69%41.08M

-7.87%38.89M

-9.99%44.48M

-39.62%43.2M

-42.96%47.05M

-58.26%42.21M

16.61%49.42M

201.10%71.56M

-Accounts payable

21.56%54.07M

54.13%66.59M

-12.69%41.08M

-7.87%38.89M

-9.99%44.48M

-39.62%43.2M

-42.96%47.05M

-58.26%42.21M

16.61%49.42M

201.10%71.56M

Contract liabilities

-29.94%5.52M

225.03%8.22M

216.29%11.28M

84.29%9.84M

395.71%7.88M

-1.01%2.53M

5.48%3.57M

62.10%5.34M

-35.44%1.59M

3.72%2.55M

Advance receipts

-20.43%248.24K

182.65%677.64K

18,599.28%7.04M

414.34%193.74K

18.36%311.98K

-35.15%239.75K

-87.71%37.67K

-92.66%37.67K

--263.58K

--369.71K

Salaries payable

-7.32%17.66M

-8.38%16.84M

-11.05%16.68M

9.48%39.05M

4.04%19.05M

5.46%18.38M

1.27%18.75M

12.03%35.67M

13.65%18.31M

23.94%17.43M

Taxs payable

-17.95%53.8M

54.91%97.49M

52.32%68.98M

60.56%99.69M

21.97%65.56M

25.64%62.93M

-14.93%45.28M

25.23%62.09M

23.90%53.75M

17.61%50.09M

Other payable (including interest and dividends)

-6.63%314.95M

-3.89%540.41M

-22.88%457.92M

25.84%494.66M

-11.97%337.3M

32.17%562.3M

33.89%593.76M

1.81%393.08M

11.85%383.18M

22.00%425.44M

-Other payable

----

-3.89%540.41M

----

32.17%562.3M

----

1.81%393.08M

----

22.00%425.44M

Non current liabilities due within one year

107.81%1.12M

103.25%1.21M

17.99%1.12M

-11.72%882.46K

-75.09%536.66K

-72.24%594.1K

-55.45%947.65K

-53.02%999.66K

-40.78%2.15M

-40.08%2.14M

Other current liabilities

-25.67%694.73K

295.73%1.06M

275.02%1.43M

90.82%1.28M

351.99%934.62K

-19.12%268.46K

--380.31K

56.56%670.37K

--206.78K

--331.91K

Total current liabilities

-20.72%976.37M

12.07%1.48B

9.35%1.37B

15.42%1.18B

6.24%1.23B

17.79%1.32B

6.53%1.25B

-7.52%1.03B

34.71%1.16B

62.79%1.12B

Current liabilities

Deferred tax liabilities

-84.21%2.21M

-84.08%2.22M

-83.38%2.29M

-83.69%2.29M

2.40%13.97M

1.16%13.97M

-2.91%13.76M

-10.20%14.01M

581.12%13.64M

522.10%13.81M

Long term deferred income

1.29%27.99M

2.73%28.4M

-5.59%25.97M

-6.08%25.85M

-6.51%27.63M

-6.49%27.65M

-7.60%27.51M

-9.75%27.53M

175.06%29.56M

175.00%29.57M

Lease liabilities

-62.28%740.56K

6.22%1.09M

132.81%2.01M

-1.67%1.13M

138.10%1.96M

-20.28%1.03M

-55.36%864.43K

-38.54%1.14M

-78.75%824.57K

-72.47%1.29M

Total non current liabilities

-28.99%30.94M

-25.62%31.72M

-28.16%30.27M

-31.44%29.27M

-1.04%43.57M

-4.52%42.64M

-8.16%42.14M

-11.01%42.69M

164.73%44.02M

153.11%44.66M

Total liabilities

-21.00%1.01B

10.89%1.51B

8.13%1.4B

13.55%1.21B

5.97%1.28B

16.93%1.36B

5.98%1.29B

-7.67%1.07B

37.17%1.2B

65.04%1.16B

Shareholders equity

Paid-in capital

30.00%322.32M

0.00%247.94M

Capital reserve funds

-6.14%1.19B

-0.26%1.26B

0.08%1.27B

0.06%1.27B

Surplus reserve funds

0.00%125.82M

0.12%125.82M

0.00%125.82M

3.77%125.67M

3.90%125.82M

Retained profit

14.29%1.94B

19.97%2.09B

20.08%1.96B

23.92%1.65B

21.36%1.7B

42.46%1.74B

34.05%1.63B

27.43%1.33B

11.51%1.4B

7.43%1.22B

Other composite income

-36.93%49.13M

-19.73%67.94M

-12.03%63.03M

42.43%61.21M

19.17%77.9M

1,976.50%84.64M

228.07%71.65M

183.58%42.98M

321.26%65.37M

111.72%4.08M

Shareholders equity without minority interests

6.17%3.63B

9.45%3.79B

9.44%3.66B

11.05%3.34B

10.08%3.42B

20.95%3.46B

19.39%3.34B

14.50%3.01B

8.56%3.11B

4.71%2.86B

Minority interests

24.08%33.76M

45.59%33.43M

53.67%32.8M

52.55%29.03M

44.39%27.21M

30.43%22.96M

31.42%21.35M

29.80%19.03M

21.93%18.84M

21.74%17.6M

Total shareholder equity

6.31%3.66B

9.69%3.83B

9.72%3.69B

11.31%3.37B

10.29%3.45B

21.01%3.49B

19.46%3.36B

14.59%3.03B

8.63%3.12B

4.80%2.88B

Total liabilityies and equity

-1.07%4.67B

10.03%5.34B

9.28%5.09B

11.90%4.59B

9.09%4.72B

19.83%4.85B

15.39%4.66B

7.81%4.1B

15.30%4.33B

17.10%4.05B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Sichuan Huaxin (Group) Accounting Firm (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-3.96%1.62B	35.22%1.91B	47.96%2.17B	63.16%1.86B	29.07%1.69B	53.10%1.41B	56.92%1.47B	49.11%1.14B	79.83%1.31B	20.31%922.9M
Transactional financial assets	17.02%971.12M	4.81%1.11B	-4.96%903.25M	-34.97%515.34M	36.07%829.85M	44.97%1.06B	65.54%950.39M	47.34%792.49M	180.08%609.87M	3,654.81%731.22M
Notes receivable and accounts receivable	23.97%493.47M	5.35%677.15M	18.18%518.88M	48.81%666.56M	-21.91%398.05M	10.55%642.76M	-15.46%439.06M	-16.56%447.91M	9.62%509.71M	21.93%581.43M
-Notes receivable	2,004.02%23.78M	1,087.28%29.37M	3,294.44%78.4M	1,238.72%15.63M	-96.90%1.13M	-96.22%2.47M	-96.11%2.31M	-98.22%1.17M	-2.24%36.52M	133.24%65.46M
-Accounts receivable	18.33%469.69M	1.17%647.78M	0.85%440.48M	45.71%650.93M	-16.12%396.92M	24.09%640.29M	-5.04%436.75M	-5.23%446.74M	10.65%473.19M	14.97%515.97M
Other receivables (including interest and dividends)	70.96%12.33M	-10.04%12.41M	-78.57%12.87M	-6.48%11.82M	-54.38%7.21M	-17.29%13.8M	293.83%60.05M	-1.56%12.63M	-1.68%15.81M	6.10%16.68M
-Other receivable	----	-10.04%12.41M	----	----	----	-17.29%13.8M	----	-1.56%12.63M	----	6.10%16.68M
Advance payment	112.92%30.84M	179.91%26.21M	22.70%15.36M	40.24%13.52M	-11.48%14.49M	-25.93%9.36M	17.68%12.52M	-25.14%9.64M	-59.56%16.37M	-59.95%12.64M
Inventories	19.01%137.48M	28.17%128.7M	15.36%109.37M	11.49%111.43M	14.60%115.52M	-1.82%100.41M	-22.22%94.81M	-27.21%99.95M	-15.31%100.8M	27.04%102.28M
Receivable financing	-33.72%166.12M	-4.79%205.38M	-39.17%145.39M	6.96%190.15M	94.40%250.64M	205.41%215.72M	93.96%239.03M	86.06%177.77M	78.08%128.93M	4.44%70.63M
Other current assets	46.62%62.25M	172.61%63.5M	26.62%37.13M	7.42%34.26M	85.59%42.46M	44.06%23.29M	-64.48%29.32M	-62.16%31.89M	-42.71%22.88M	-17.00%16.17M
Total current assets	4.44%3.49B	18.88%4.14B	18.88%3.92B	25.47%3.4B	23.38%3.34B	41.75%3.48B	38.23%3.29B	24.30%2.71B	59.73%2.71B	65.99%2.45B
Non Current assets
Other equity investment	238.25%33.83M	--33.83M	--13.83M	--11M	--10M	----	----	----	----	----
Other non-current financial assets	-35.60%12.78M	-35.60%12.78M	-35.60%12.78M	-35.60%12.78M	0.00%19.84M	0.00%19.84M	0.00%19.84M	0.00%19.84M	0.00%19.84M	0.00%19.84M
Investment real estate	-5.16%128.55M	-4.99%130.39M	-4.94%132.2M	-4.84%134.07M	-5.02%135.55M	-5.05%137.24M	-4.98%139.07M	-4.92%140.89M	354.23%142.71M	354.19%144.54M
Long-term equity investment	-13.24%89.76M	-12.87%90.47M	-12.00%91.29M	-15.53%92.85M	-3.87%103.47M	-3.81%103.84M	-4.23%103.74M	-0.44%109.91M	-5.68%107.63M	-8.62%107.96M
Fixed assets	----	35.28%521.29M	----	----	----	-20.25%385.33M	----	-18.91%395.87M	----	188.17%483.16M
Constru in process	----	-70.61%63.71M	----	----	----	-23.85%216.81M	----	-43.56%153.6M	----	-35.71%284.7M
Intangible assets	-55.18%181.73M	-54.13%190.55M	-51.45%196.24M	-51.39%202.46M	-5.98%405.44M	-0.38%415.38M	0.22%404.23M	1.17%416.48M	-51.73%431.24M	-53.92%416.97M
Development expenditure	2.85%1.33M	4.05%1.34M	3.23%1.32M	3.07%1.31M	3.10%1.29M	2.91%1.28M	-97.34%1.28M	-97.17%1.27M	-97.30%1.26M	-96.33%1.25M
Goodwill	0.00%8.88M	0.00%8.88M	0.00%8.88M	0.00%8.88M	0.00%8.88M	0.00%8.88M	0.00%8.88M	0.00%8.88M	0.00%8.88M	0.00%8.88M
Long deferred expense	-48.18%456.41K	-44.09%605.33K	-64.07%451.87K	-58.91%625.14K	-58.03%880.75K	-55.40%1.08M	-54.37%1.26M	-47.02%1.52M	36.94%2.1M	218.70%2.43M
Deferred tax assets	59.17%135.67M	89.95%134.97M	65.69%116.47M	61.87%115.48M	25.76%85.24M	14.04%71.06M	2.85%70.3M	6.22%71.34M	144.79%67.78M	192.09%62.31M
Usufruct assets	-15.53%1.89M	47.75%2.18M	117.60%3.19M	8.44%2.07M	-17.43%2.23M	-52.52%1.47M	-59.98%1.46M	-54.95%1.91M	-59.48%2.71M	-57.54%3.1M
Other non current assets	32.12%10.7M	8.97%9.74M	-30.60%6.9M	-92.86%4.72M	-87.03%8.1M	-84.53%8.94M	-85.91%9.94M	55.87%66.07M	-38.46%62.42M	-73.73%57.81M
Total non current assets	-14.44%1.18B	-12.43%1.2B	-13.93%1.17B	-14.64%1.18B	-14.85%1.38B	-13.92%1.37B	-17.56%1.36B	-14.39%1.39B	-21.34%1.62B	-19.45%1.59B
Total assets	-1.07%4.67B	10.03%5.34B	9.28%5.09B	11.90%4.59B	9.09%4.72B	19.83%4.85B	15.39%4.66B	7.81%4.1B	15.30%4.33B	17.10%4.05B
Liabilities
Current liabilities
Short term loan	-30.07%528.32M	18.64%746.4M	40.93%761.55M	2.86%499.99M	16.17%755.52M	14.30%629.14M	-5.20%540.37M	-9.08%486.1M	58.63%650.38M	117.53%550.41M
Notes payable and accounts payable	21.56%54.07M	54.13%66.59M	-12.69%41.08M	-7.87%38.89M	-9.99%44.48M	-39.62%43.2M	-42.96%47.05M	-58.26%42.21M	16.61%49.42M	201.10%71.56M
-Accounts payable	21.56%54.07M	54.13%66.59M	-12.69%41.08M	-7.87%38.89M	-9.99%44.48M	-39.62%43.2M	-42.96%47.05M	-58.26%42.21M	16.61%49.42M	201.10%71.56M
Contract liabilities	-29.94%5.52M	225.03%8.22M	216.29%11.28M	84.29%9.84M	395.71%7.88M	-1.01%2.53M	5.48%3.57M	62.10%5.34M	-35.44%1.59M	3.72%2.55M
Advance receipts	-20.43%248.24K	182.65%677.64K	18,599.28%7.04M	414.34%193.74K	18.36%311.98K	-35.15%239.75K	-87.71%37.67K	-92.66%37.67K	--263.58K	--369.71K
Salaries payable	-7.32%17.66M	-8.38%16.84M	-11.05%16.68M	9.48%39.05M	4.04%19.05M	5.46%18.38M	1.27%18.75M	12.03%35.67M	13.65%18.31M	23.94%17.43M
Taxs payable	-17.95%53.8M	54.91%97.49M	52.32%68.98M	60.56%99.69M	21.97%65.56M	25.64%62.93M	-14.93%45.28M	25.23%62.09M	23.90%53.75M	17.61%50.09M
Other payable (including interest and dividends)	-6.63%314.95M	-3.89%540.41M	-22.88%457.92M	25.84%494.66M	-11.97%337.3M	32.17%562.3M	33.89%593.76M	1.81%393.08M	11.85%383.18M	22.00%425.44M
-Other payable	----	-3.89%540.41M	----	----	----	32.17%562.3M	----	1.81%393.08M	----	22.00%425.44M
Non current liabilities due within one year	107.81%1.12M	103.25%1.21M	17.99%1.12M	-11.72%882.46K	-75.09%536.66K	-72.24%594.1K	-55.45%947.65K	-53.02%999.66K	-40.78%2.15M	-40.08%2.14M
Other current liabilities	-25.67%694.73K	295.73%1.06M	275.02%1.43M	90.82%1.28M	351.99%934.62K	-19.12%268.46K	--380.31K	56.56%670.37K	--206.78K	--331.91K
Total current liabilities	-20.72%976.37M	12.07%1.48B	9.35%1.37B	15.42%1.18B	6.24%1.23B	17.79%1.32B	6.53%1.25B	-7.52%1.03B	34.71%1.16B	62.79%1.12B
Current liabilities
Deferred tax liabilities	-84.21%2.21M	-84.08%2.22M	-83.38%2.29M	-83.69%2.29M	2.40%13.97M	1.16%13.97M	-2.91%13.76M	-10.20%14.01M	581.12%13.64M	522.10%13.81M
Long term deferred income	1.29%27.99M	2.73%28.4M	-5.59%25.97M	-6.08%25.85M	-6.51%27.63M	-6.49%27.65M	-7.60%27.51M	-9.75%27.53M	175.06%29.56M	175.00%29.57M
Lease liabilities	-62.28%740.56K	6.22%1.09M	132.81%2.01M	-1.67%1.13M	138.10%1.96M	-20.28%1.03M	-55.36%864.43K	-38.54%1.14M	-78.75%824.57K	-72.47%1.29M
Total non current liabilities	-28.99%30.94M	-25.62%31.72M	-28.16%30.27M	-31.44%29.27M	-1.04%43.57M	-4.52%42.64M	-8.16%42.14M	-11.01%42.69M	164.73%44.02M	153.11%44.66M
Total liabilities	-21.00%1.01B	10.89%1.51B	8.13%1.4B	13.55%1.21B	5.97%1.28B	16.93%1.36B	5.98%1.29B	-7.67%1.07B	37.17%1.2B	65.04%1.16B
Shareholders equity
Paid-in capital	30.00%322.32M	30.00%322.32M	0.00%247.94M	0.00%247.94M	0.00%247.94M	0.00%247.94M	0.00%247.94M	0.00%247.94M	0.00%247.94M	0.00%247.94M
Capital reserve funds	-6.14%1.19B	-6.14%1.19B	-0.26%1.26B	-0.26%1.26B	0.08%1.27B	0.08%1.27B	0.08%1.27B	0.08%1.27B	0.06%1.27B	0.06%1.27B
Surplus reserve funds	0.00%125.82M	0.00%125.82M	0.00%125.82M	0.00%125.82M	0.12%125.82M	0.00%125.82M	0.00%125.82M	0.00%125.82M	3.77%125.67M	3.90%125.82M
Retained profit	14.29%1.94B	19.97%2.09B	20.08%1.96B	23.92%1.65B	21.36%1.7B	42.46%1.74B	34.05%1.63B	27.43%1.33B	11.51%1.4B	7.43%1.22B
Other composite income	-36.93%49.13M	-19.73%67.94M	-12.03%63.03M	42.43%61.21M	19.17%77.9M	1,976.50%84.64M	228.07%71.65M	183.58%42.98M	321.26%65.37M	111.72%4.08M
Shareholders equity without minority interests	6.17%3.63B	9.45%3.79B	9.44%3.66B	11.05%3.34B	10.08%3.42B	20.95%3.46B	19.39%3.34B	14.50%3.01B	8.56%3.11B	4.71%2.86B
Minority interests	24.08%33.76M	45.59%33.43M	53.67%32.8M	52.55%29.03M	44.39%27.21M	30.43%22.96M	31.42%21.35M	29.80%19.03M	21.93%18.84M	21.74%17.6M
Total shareholder equity	6.31%3.66B	9.69%3.83B	9.72%3.69B	11.31%3.37B	10.29%3.45B	21.01%3.49B	19.46%3.36B	14.59%3.03B	8.63%3.12B	4.80%2.88B
Total liabilityies and equity	-1.07%4.67B	10.03%5.34B	9.28%5.09B	11.90%4.59B	9.09%4.72B	19.83%4.85B	15.39%4.66B	7.81%4.1B	15.30%4.33B	17.10%4.05B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Sichuan Huaxin (Group) Accounting Firm (Special General Partnership)	--	--	--	Sichuan Huaxin (Group) Accounting Firm (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

600211 Tibet Rhodiola Pharmaceutical Holding

Tibet Rhodiola Pharmaceutical Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target